Abstract
BackgroundImmunotherapy has transformed lung cancer care and tremendously improved outcomes over the last decade. However, the majority of many immunotherapy trials contain overly restrictive criteria, excluding many patients and resulting...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
